Theresa Kim1, Neeraj Chhabra2, Danielle Mae Weech3, Jerrold B Leikin1,4. 1. Division of Emergency Medicine, NorthShore University Health System, Evanston, IL, USA. 2. Department of Emergency Medicine, Division of Medical Toxicology, Cook County Health, 1950 W Polk Street, Chicago, IL, 60612, USA. nchhabra@cookcountyhhs.org. 3. Gift of Hope Organ & Tissue Donor Network, Itasca, IL, USA. 4. OMEGA, NorthShore University Health System, Glenview, IL, USA.
Abstract
BACKGROUND: A gap exists between the number of patients on the national organ transplant waiting list and the number of transplants performed. Victims of drug and overdose-related death are increasingly utilized as organ donors. We sought to evaluate the suitability of organs from drug and overdose-related death for organ transplantation. This study compares the proportion of short-term allograft failure of organs procured from patients with drug-related deaths with those without drug-related deaths. METHODS: Organ donations after drug-related deaths (DDD) were compared with organ donations from non-drug-related donations after brain deaths (DBD) and donations after circulatory deaths (DCD) utilizing the Gift of Hope Organ & Tissue Donor Network for a total of 15 months. RESULTS: Eighty-one donors were identified from each of the DDD, DBD, and DCD groups with 264, 234, and 181 organs transplanted, respectively. The proportions of short-term graft failures were 1.15% in the DDD group compared with 2.14% in the DBD group (p = NS) and 5.52% in the DCD group (p = 0.01). The US Public Health Service increased-risk features for transmission of infectious diseases were present in 70.3% of the DDD cases. Donors from the DDD group were younger on average than those in other groups (33 to 42 years). CONCLUSIONS: The proportion of graft failures in the drug-related deaths (DDD) group was equal to or less than those from other causes of death on short-term follow-up. Drug-related death does not appear to be a contraindication for organ procurement despite increased risk features for infectious disease transmission.
BACKGROUND: A gap exists between the number of patients on the national organ transplant waiting list and the number of transplants performed. Victims of drug and overdose-related death are increasingly utilized as organ donors. We sought to evaluate the suitability of organs from drug and overdose-related death for organ transplantation. This study compares the proportion of short-term allograft failure of organs procured from patients with drug-related deaths with those without drug-related deaths. METHODS: Organ donations after drug-related deaths (DDD) were compared with organ donations from non-drug-related donations after brain deaths (DBD) and donations after circulatory deaths (DCD) utilizing the Gift of Hope Organ & Tissue Donor Network for a total of 15 months. RESULTS: Eighty-one donors were identified from each of the DDD, DBD, and DCD groups with 264, 234, and 181 organs transplanted, respectively. The proportions of short-term graft failures were 1.15% in the DDD group compared with 2.14% in the DBD group (p = NS) and 5.52% in the DCD group (p = 0.01). The US Public Health Service increased-risk features for transmission of infectious diseases were present in 70.3% of the DDD cases. Donors from the DDD group were younger on average than those in other groups (33 to 42 years). CONCLUSIONS: The proportion of graft failures in the drug-related deaths (DDD) group was equal to or less than those from other causes of death on short-term follow-up. Drug-related death does not appear to be a contraindication for organ procurement despite increased risk features for infectious disease transmission.
Entities:
Keywords:
Graft failure; Opioid; Organ donation; Overdose; Transplant
Authors: Matthew Goss; Jeffrey Reese; Michael Kueht; John M Vierling; Ayse L Mindikoglu; Norman L Sussman; Bruce Kaplan; R Patrick Wood; Abbas A Rana Journal: Liver Transpl Date: 2017-05 Impact factor: 5.799
Authors: Mandeep R Mehra; John A Jarcho; Wida Cherikh; Muthiah Vaduganathan; Rebecca R Lehman; Jacqueline Smits; Josef Stehlik Journal: N Engl J Med Date: 2018-05-17 Impact factor: 91.245
Authors: William M Whited; Mickey S Ising; Jaimin R Trivedi; Matthew P Fox; Victor van Berkel Journal: Clin Transplant Date: 2018-05-07 Impact factor: 2.863
Authors: Christine M Durand; Mary G Bowring; Alvin G Thomas; Lauren M Kucirka; Allan B Massie; Andrew Cameron; Niraj M Desai; Mark Sulkowski; Dorry L Segev Journal: Ann Intern Med Date: 2018-04-17 Impact factor: 25.391
Authors: Vanessa L Richards; Christopher K Johnson; James D Perkins; Ajit P Limaye; Lena Sibulesky Journal: Ann Transplant Date: 2018-06-05 Impact factor: 1.530